AItheNutrigene Co (XKRX:311960) EBITDA Margin % : -24.23% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is AItheNutrigene Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. AItheNutrigene Co's EBITDA for the six months ended in Dec. 2023 was ₩-2,216 Mil. AItheNutrigene Co's Revenue for the six months ended in Dec. 2023 was ₩9,147 Mil. Therefore, AItheNutrigene Co's EBITDA margin for the quarter that ended in Dec. 2023 was -24.23%.

AItheNutrigene Co EBITDA Margin % Historical Data

The historical data trend for AItheNutrigene Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AItheNutrigene Co EBITDA Margin % Chart

AItheNutrigene Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

23.17

13.81

-11.81

-24.23

AItheNutrigene Co Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
EBITDA Margin %	23.17	13.81	-11.81	-24.23

Competitive Comparison of AItheNutrigene Co's EBITDA Margin %

For the Medical Devices subindustry, AItheNutrigene Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AItheNutrigene Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AItheNutrigene Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where AItheNutrigene Co's EBITDA Margin % falls into.

AItheNutrigene Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

AItheNutrigene Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2216.411	/	9147
	=	-24.23 %

AItheNutrigene Co's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2216.411	/	9147
	=	-24.23 %

AItheNutrigene Co (XKRX:311960) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

AItheNutrigene Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of AItheNutrigene Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

AItheNutrigene Co (XKRX:311960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AItheNutrigene Co Ltd (XKRX:311960) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

630, 42 Changdeok-ro, Siheung-dong, Pangyo 2nd Techno Valley Gyeonggi Business Growth Center, Sujeong-gu, Gyeonggi-do, Seongnam-si, KOR

Website

http://www.aithenutrigene.com

AItheNutriGene Co engages in developing a test-detection solution in order to check out the early detection of various diseases. The company offers molecular diagnostic technology, nutrition therapy customized according to an individual's genomics and AI bio, enabling patients and medical practitioners with tests and accurate diagnoses to prevent diseases.

AItheNutrigene Co (XKRX:311960) Headlines

No Headlines